Recent developments in the field of obesity treatment have presented a new drug known as ALLUVI Retatrutide. This compound is a {highlypotent GLP-1 receptor agonist, designed to mimic the effects of natural glucagon-like peptide-1. Retatrutide has shown significant results in clinical trials, highlighting significant reductions in body weight and a